cro.directory
← Compare landing

Aurigene Pharmaceutical Services Limited vs R2M Pharma, Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aurigeneservices/r2mpharma

CategoryAurigene Pharmaceutical Services LimitedR2M Pharma, Inc.
Listed sitebothcro
SummaryIntegrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.R2M Pharma is a medicinal chemistry CRO specializing in small-molecule drug discovery and preclinical development, from hit validation through GLP toxicology studies.
Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • High-Throughput Screening
  • Computational & In-Silico Drug Discovery
  • Protein Engineering
  • Medicinal Chemistry
  • Discovery Research
  • GLP Toxicology
Modalities
  • Small Molecule
  • Biologics (Other)
  • Peptide
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Manufacturing - India, India
  • Manufacturing - UK, United Kingdom
  • Manufacturing - Mexico, Mexico
  • Headquarters, South San Francisco, CA, USA
Certifications
  • FDA · Identifier: 16 US FDA-inspected cGMP facilities
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.